ReposiTrak insider report: 7,000 shares sold under 10b5-1 plan
Rhea-AI Filing Summary
Randall K. Fields, CEO, Director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple dispositions of company stock on 09/22/2025 and 09/23/2025. The report shows sales of 3,000 shares on 09/22/2025 at a weighted average price of $17.5775 and 4,000 shares on 09/23/2025 at a weighted average price of $17.3856, executed pursuant to a Rule 10b5-1 trading plan established by the reporting person as trustee of a charitable unitrust.
The Form 4 discloses significant other holdings and dispositions: a reported disposition of 3,683,955 shares of common stock, direct ownership of 615,260 shares indirectly, and various indirect holdings through Riverview Financial Corp., spouse, Fields Management, Inc., and a charitable LLC. Footnotes state the sales occurred in multiple transactions and provide price ranges for each weighted average.
Positive
- Sales executed under a Rule 10b5-1 trading plan, indicating pre-established automated dispositions
- Weighted average prices and price ranges disclosed with offer to provide per-price details on request
- Comprehensive beneficial ownership disclosure including direct and indirect holdings through related entities
Negative
- Insider disposed of shares (3,000 on 09/22/2025 and 4,000 on 09/23/2025) as reported on Form 4
- Large reported disposition of 3,683,955 common shares is listed on the form as a disposal
- Substantial indirect holdings and dispositions through affiliated entities and spouse are disclosed, increasing complexity of ownership
Insights
TL;DR: Insider sales occurred under a pre-established 10b5-1 plan; small executed trades and large prior dispositions are reported.
The filing documents routine sales on 09/22/2025 and 09/23/2025 totaling 7,000 shares at weighted average prices of $17.5775 and $17.3856 respectively, and specifies the trades were automatic under a 10b5-1 plan tied to the reporting person's charitable trust. The Form 4 also lists a large disposition of 3,683,955 common shares and multiple indirect holdings via related entities and spouse. For investors, the key facts are the method of sale (Rule 10b5-1) and the magnitude of other reported dispositions and indirect holdings disclosed on the form.
TL;DR: Governance disclosure is explicit; trades are tied to a charitable plan and footnotes document weighted average pricing ranges.
The disclosure clearly states the reported sales were executed under a Rule 10b5-1 plan established by the reporting person as trustee for a charitable unitrust, which supports an affirmative defense for insider trading when properly adopted. Footnotes provide price ranges and offer to supply detailed per-price allocations upon request. The Form 4 identifies related-party and indirect ownership through multiple entities, consistent with comprehensive beneficial-ownership reporting requirements.